In 2015, Masahiko Watanabe's team found that KK-LC-1 was highly expressed in gastric cancer, and the expression was higher than that of other CTAs, such as MAGE-A1, MAGE-A3 and NY-ESO-1 [48]. The gene discussed is CT83; the disease is gastric cancer.